天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (5): 989-995.doi: 10.16333/j.1001-6880.2026.5.007 cstr: 32307.14.1001-6880.2026.5.007

• 研究简报 • 上一篇    下一篇

基于OSMAC策略的缬草药材内生真菌Aspergillus sp.FH-2中次生代谢产物研究

樊  浩,王  鑫,吴怡轩,张东东,王  薇,宋小妹,李玉泽*,邓  翀*   

  1. 陕西中医药大学药学院 陕西省太白七药研究与应用重点研究室,咸阳 712046
  • 出版日期:2026-05-26 发布日期:2026-05-26
  • 基金资助:
    陕西省教育厅科学研究项目(25JK0430);陕西省“三秦英才”引进计划;国家中医药管理局重点学科项目(zyyzdxk-2023202);大学生创新训练计划项目(S202510716010)

Secondary metabolites from endophytic fungus Aspergillus sp.FH-2 in Valeriana officinalis L. based on the OSMAC strategy

FAN Hao,WANG Xin,WU Yi-xuan,ZHANG Dong-dong,WANG Wei,SONG Xiao-mei,LI Yu-ze*,DENG Chong*   

  1. School of Pharmacy,Shaanxi University of Chinese Medicine,Shaanxi Key Laboratory of Research and Application of “Taibai Qi Yao”,Xianyang 712046,China
  • Online:2026-05-26 Published:2026-05-26

摘要:

研究缬草药材内生真菌Aspergillus sp. FH-2大米培养基中抗真菌次生代谢产物。基于单菌多次级代谢产物(one strain many compounds,OSMAC)策略筛选出优势培养基,进行规模培养,采用硅胶和ODS柱色谱以及半制备液相色谱等方法进行分离纯化,并结合其理化性质及核磁共振、红外、质谱等波谱学技术进行结构解析。从Aspergillus sp. FH-2菌株的乙酸乙酯提取部位分离得到8个化合物,分别鉴定为asperalipha A(1)、questin(2)、6,8-dihydroxy-3-methylisocoumarin(3)、3,6,8-三羟基-3,5,7-三甲基-3,4-二氢异香豆素(4)、5-羟基-2-甲氧基-7-甲基-1,4-萘醌(5)、7-drimen-9α,11,12-triol(6)、吲哚-3-甲酸甲酯(7)和N-[2-(4-hydroxyphenyl) ethenyl]formamide(8)。其中,化合物1为新化合物。采用菌丝生长速率法测定了所有化合物对木瓜炭疽病菌(Colletotrichum gloeosporioides)的抗真菌活性。结果显示,化合物1的抑制效果高于阳性对照多菌灵,化合物24也表现出中等抑制效果,其有效中浓度(median effective concentration,EC50)为43.12~79.04 μg/mL。分子对接结果表明,化合物1与靶蛋白的结合能力强于阳性对照药物(多菌灵),其结合能为-6.30 kcal/mol。

关键词: 缬草, Aspergillus sp. FH-2, OSMAC策略, 结构鉴定, 抗真菌, 分子对接

Abstract:

This study aims to investigate the antifungal secondary metabolites from the endophytic fungus Aspergillus sp. FH-2 isolated from Valeriana officinalis L., cultured on a rice medium. Based on the one strain many compounds (OSMAC) strategy, the optimal culture medium was first screened to facilitate large-scale fermentation. The metabolites were then isolated and purified using a combination of silica gel chromatography, ODS column chromatography, and semi-preparative liquid chromatography. Structural elucidation of the obtained compounds was carried out by comprehensive analysis of their physicochemical properties and spectroscopic data, including NMR, IR, and MS. Eight compounds were isolated from the ethyl acetate extract of the Aspergillus sp. FH-2 strain. These were identified as: asperalipha A (1), questin (2), 6,8-dihydroxy-3-methylisocoumarin (3), 3,6,8-trihydroxy-3,5,7-trimethyl-3,4-dihydroisocoumarin (4), 5-hydroxy-2-methoxy-7-methyl-1,4-naphthoquinone (5), 7-drimen-9α,11,12-triol (6), methyl indole-3-carboxylate (7), and N-[2-(4-hydroxyphenyl)ethenyl] formamide (8). Among these, compound 1 was identified as a new compound. The antifungal activities of all compounds against Colletotrichum gloeosporioides were determined using the mycelial growth rate method. The results indicated that compound 1 exhibited superior inhibitory efficacy compared to the positive control carbendazim. Compounds 2 and 4 also demonstrated moderate inhibition, with EC₅₀ values ranging from 43.12 to 79.04 μg/mL. Molecular docking results revealed that compound 1 possesses a stronger binding affinity to the target protein than the positive control drug (carbendazim), with a binding energy of -6.30 kcal/mol.

Key words: Valeriana officinalis L., Aspergillus sp. FH-2, OSMAC strategy, structural elucidation; antifungal, molecular docking

中图分类号:  R284